Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
07/2006
07/26/2006CN1809531A Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
07/26/2006CN1807651A Cytochrome C oxidase enzyme complex
07/26/2006CN1807421A High optical activity chiral phthalide analog compound and synthesis method
07/26/2006CN1807411A Unsaturated five heterocycle compound for up-regulating bone formation protein BMP-2 expression activity
07/26/2006CN1266154C Method for producing pyromellitic dianhydride
07/26/2006CN1266147C Synthesis for organic sulfur compound in hydrous medium
07/26/2006CN1266143C Process for preparing 5-cynophenyl phthaleine
07/26/2006CN1266142C Polysubstituted benzo hetero aromatic ring and method for one step synthesizing polysubstituted benzo hetero aromatic ring
07/26/2006CN1266141C Systems and methods for generation of ascorbic acid with reduced color
07/26/2006CN1266140C Process for preparing oxazolines from tetrahydrofurans
07/26/2006CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
07/26/2006CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/25/2006CA2289209C Cyclic ether vitamin d3 compounds, 1.alpha. (oh) 3-epi-vitamin d3 compounds and uses thereof
07/25/2006CA2072785C Pharmacologically active hydrazine derivatives and processes for the preparation thereof
07/20/2006WO2006076564A1 Synthesis of himbacine analogs
07/20/2006WO2006076452A2 An exo-selective synthesis of himbacine analogs
07/20/2006WO2006076415A2 Exo- and diastereo- selective syntheses of himbacine analogs
07/20/2006WO2006076202A1 Heterocyclic carboxamide compounds as steroid nuclear receptors ligands
07/20/2006WO2006075651A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE β-HYDROXY-α-AMINOCARBOXYLIC ACID DERIVATIVE
07/20/2006WO2006074796A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
07/20/2006WO2006047756A3 Substituted tetracycline compounds
07/20/2006WO2005121130A3 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
07/20/2006WO2005051895A8 Organic compounds
07/20/2006US20060160891 Process for producing powdered compositions containing highly unsaturated fatty acid esters of ascorbic acid and powdered compositions containing the esters
07/20/2006US20060160875 Matrix metalloproteinase inhibitors
07/20/2006US20060160856 Diarylurea derivatives and their use as chloride channel blockers
07/20/2006US20060160832 Nitrogen-containing aromatic derivatives
07/20/2006US20060160802 Antibiotics; e.g N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-trifluoromethyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide; N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-methyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide
07/20/2006US20060160773 Combretastatin derivatives with cytotoxic action
07/20/2006US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy
07/20/2006DE102005000957A1 Verfahren zur Herstellung von spezifikationsgerechtem Phthalsäureanhydrid Process for the preparation of on-spec phthalic anhydride
07/20/2006CA2594871A1 Exo- and diastereo- selective syntheses of himbacine analogs
07/20/2006CA2594807A1 An exo-selective synthesis of himbacine analogs
07/20/2006CA2594741A1 Synthesis of himbacine analogs
07/20/2006CA2594384A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
07/20/2006CA2593156A1 Heterocyclic carboxamide compounds as steroid nuclear receptors ligands
07/19/2006EP1681291A1 Process for the preparation of norgalanthamine, its isomers, salts and hydrates
07/19/2006EP1681285A1 Diamine derivative, process for producing the same, and plant disease control agent containing the same as active ingredient
07/19/2006EP1681280A1 Novel phenol derivatives and antitrypanosoma preventive/therapeutic agent containing the same as active ingredient
07/19/2006EP1680411A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
07/19/2006EP1680407A1 Isopentyl carboxanilides for combating undesired micro-organisms
07/19/2006EP1680129A2 Inosine monophosphate dehydrogenase inhibitors as phosphonate derivatives
07/19/2006EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
07/19/2006EP1451133A4 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
07/19/2006CN1805949A Bis (fluorine-containing phthalic anhydride) and method for production thereof
07/19/2006CN1805948A Stabilized derivatives of ascorbic acid.
07/19/2006CN1805947A Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[1(r)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-l]aminobenzamide
07/19/2006CN1805946A Production of 5-methyl-dihydro-furan-2-one from levulinic acid in supercritical media
07/19/2006CN1805943A Alpha substituted carboxylic acid as PPAR modulators
07/19/2006CN1805915A Indene derivatives as pharmaceutical agents
07/19/2006CN1803786A Red sage root water soluble ingredient derivative ERJT-12 and its application in cancer resistance
07/19/2006CN1803785A Method for preparing furfural by utilizing cotton stalk
07/19/2006CN1264839C Non-nucleoside reverse transcriptase inhibitors
07/19/2006CN1264832C Polyhydric phenols, epoxy resins, epoxy resin composition, and cured products thereof
07/19/2006CN1264819C Process for stereo selective synthesis of prostacyclin derivatives
07/19/2006CN1264803C Aromatic esters for marking or tagging organic products
07/18/2006USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals
07/18/2006US7078565 Benzamide derivatives as antagonists of orexin receptors
07/18/2006US7078542 pi-electron donor group bonded to a pi-electron conjugated bridge group bonded to a mono- or dicyanodihydrofuran acceptor; large hyperpolarizability, dipole moment, and electrooptic coefficients; electrooptics
07/18/2006US7078541 Antiinflammatory agents; antiischemic agents; central nervous system disorders; prevent tissue degradation
07/18/2006US7078435 Autoinducer compounds
07/18/2006US7078432 Process for the preparation of the 14β-hydroxy-baccatin III-1,14-carbonate
07/18/2006US7078404 Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
07/18/2006CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
07/18/2006CA2309771C New substitute dimeric derivatives, their preparation process and the pharmaceutical compositions that contain them
07/18/2006CA2224528C Stilbene compositions in the adamantyl group, compositions containing them and uses
07/13/2006WO2006072463A1 Method for producing phthalic anhydride that conforms to specifications
07/13/2006WO2006021971A3 'process for preparation of citalopram and enantiomers'
07/13/2006WO2006002088A3 Amino-quinazoline derivatives as antitumor agents
07/13/2006WO2005112945A3 Synthesis of tetracyclines and analogues thereof
07/13/2006US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria,
07/13/2006US20060154977 Therapeutic molecules and methods-1
07/13/2006US20060154912 Isophtalic acid derivatives
07/13/2006DE102004063801A1 Preparation of ascorbic acid granulates, used for preparing particulate shaped washing/cleaning agents, comprises granulation of ascorbic acid, a water-soluble polymer, as bonding agents, and optionally an inorganic carrier material
07/13/2006DE102004063443A1 Verfahren zur Herstellung von optisch aktiven cyclischen Aminen A process for preparing optically active cyclic amines
07/12/2006EP1679070A1 Use of l-butylphthalide in the manufacture of medicaments for prevention and treatment of cerebral infarct
07/12/2006EP1678156A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
07/12/2006EP1678154A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
07/12/2006EP1678142A1 Hexyl carboxanilides and their use for controlling undesirable micro-organisms
07/12/2006EP1678141A1 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
07/12/2006EP1678122A1 Improved process for the manufacture of citalopram hydrobromide
07/12/2006EP1678108A1 Homogeneous process for the hydrogenation of dicarboxylic acids and/or anhydrides thereof
07/12/2006EP1677782A2 Inhibitors of cathepsin s
07/12/2006EP1394156B1 Chromene compound
07/12/2006EP1222163B1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds
07/12/2006CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes.
07/12/2006CN1800176A Heterocyclic sulfonamide inhibitors of beta amyloid production
07/12/2006CN1800170A Method of purifying dianhydrides
07/12/2006CN1800145A Substituted 2-dialkylaminoalkylbiphenyl derivatives
07/12/2006CN1263750C Heterocyclic sulfonamide inhibitors from beta amyloid
07/12/2006CN1263749C Preparation process and apparatus for alpha-acetyl-gamma-butyrolactone
07/12/2006CN1263731C Novel immunotherapeutic agents and their use in production of cytokine levels
07/12/2006CN1263726C Process and intermediates to prepare latanoprost
07/11/2006US7074970 Process for producing vinyl ether compounds
07/11/2006US7074952 Synthesis of taxol enhancers
07/11/2006US7074944 single-stage preparation of polytetrahydrofuran and/or tetrahydrofuran copolymers having a mean molecular weight of from 650 to 5000 dalton by polymerization of tetrahydrofuran over an acid catalyst in the presence of a telogen and/or comonomer
07/11/2006US7074934 Serine protease inhibitors
07/11/2006US7074838 Process for the catalytic oxidation of hydrocarbons
07/11/2006US7074836 Para-terphenyl compounds
07/11/2006US7074826 R-NSAID esters and their use